Northeast Patients Group v. United Cannabis Patients and Caregivers of Maine

45 F.4th 542
CourtCourt of Appeals for the First Circuit
DecidedAugust 17, 2022
Docket21-1719P
StatusPublished
Cited by17 cases

This text of 45 F.4th 542 (Northeast Patients Group v. United Cannabis Patients and Caregivers of Maine) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Northeast Patients Group v. United Cannabis Patients and Caregivers of Maine, 45 F.4th 542 (1st Cir. 2022).

Opinion

United States Court of Appeals For the First Circuit

No. 21-1719

NORTHEAST PATIENTS GROUP, d/b/a Wellness Connection of Maine; HIGH STREET CAPITAL PARTNERS, LLC,

Plaintiffs, Appellees,

v.

UNITED CANNABIS PATIENTS AND CAREGIVERS OF MAINE,

Intervenor-Defendant, Appellant,

MAINE DEPARTMENT OF ADMINISTRATIVE AND FINANCIAL SERVICES; KIRSTEN FIGUEROA, Commissioner of the Maine Department of Administrative and Financial Services,

Defendants.

No. 21-1759

NORTHEAST PATIENTS GROUP, d/b/a Wellness Connection of Maine; HIGH STREET CAPITAL PARTNERS, LLC,

KIRSTEN FIGUEROA, Commissioner of the Maine Department of Administrative and Financial Services,

Defendant, Appellant,

MAINE DEPARTMENT OF ADMINISTRATIVE AND FINANCIAL SERVICES; UNITED CANNABIS PATIENTS AND CAREGIVERS OF MAINE,

Defendants. APPEALS FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MAINE

[Hon. Nancy Torresen, U.S. District Judge]

Before

Barron, Chief Judge, Lynch and Gelpí, Circuit Judges.

Matthew Warner, with whom Jonathan Mermin, Alexandra Harriman, and Preti, Flaherty, Beliveau & Pachios, LLP were on brief, for appellees. James G. Monteleone, with whom Bernstein Shur was on brief, for appellant United Cannabis Patients and Caregivers of Maine. Christopher C. Taub, Chief Deputy Attorney General of Maine, with whom Aaron M. Frey, Attorney General of Maine, Thomas A. Knowlton, Deputy Attorney General of Maine, and Paul E. Suitter, Assistant Attorney General of Maine, were on brief, for appellant Kirsten Figueroa.

August 17, 2022 BARRON, Chief Judge. This appeal concerns whether the

Maine Medical Use of Marijuana Act, 22 M.R.S. §§ 2421-2430 (2009)

("Maine Medical Marijuana Act"), violates what is known as the

dormant Commerce Clause of the United States Constitution by

requiring "officers" and "directors" of medical marijuana

"dispensar[ies]," id. § 2428(6)(H), operating in Maine to be Maine

residents. The United States District Court for the District of

Maine held that Maine Medical Marijuana Act's residency

requirement does violate the dormant Commerce Clause,

notwithstanding that Congress enacted the Controlled Substances

Act ("CSA"), 21 U.S.C. § 801 et seq., to "eradicate the market" in

marijuana, see Gonzalez v. Raich, 545 U.S. 1, 19 n.29 (2005). The

District Court concluded that is so, because the residency

requirement is a facially protectionist state regulation of an

interstate market in medical marijuana that continues to operate

even in the face of the CSA. We affirm.

I.

Maine enacted the Maine Medical Marijuana Act in 2009 to

authorize participation in the market in medical marijuana in that

state in specified circumstances. See Maine Medical Use of

Marijuana Act, 22 M.R.S. §§ 2421-2430 (2009) (the "Medical

Marijuana Act") (permitting the "acquisition, possession,

cultivation, manufacture, use, delivery, transfer or

transportation of marijuana" relating to prescribed treatments for

- 3 - certain medical conditions). Among other things, the Maine Medical

Marijuana Act provides that a "dispensary" may sell medical

marijuana in the state, so long as certain requirements are

satisfied. Id. It then goes on to define a "dispensary" as "an

entity registered under [22 M.R.S. § 2425-A] that acquires,

possesses, cultivates, manufactures, delivers, transfers,

transports, sells, supplies or dispenses marijuana plants or

harvested marijuana or related supplies and educational materials

to qualifying patients and the caregivers of those patients." Id.

§ 2422(6).

The residency requirement that is at issue in this appeal

appears in § 2428(6)(H) of the Maine Medical Marijuana Act. It

provides that, for a "dispensary" to be authorized under state law

to sell "medical marijuana" in Maine, "all [the] officers or

directors of a dispensary must be residents of [Maine]." Id.

§ 2422(6)(H) (the "residency requirement"). The phrase "[o]fficer

or director" is then defined broadly in a separate provision of

the Maine Medical Marijuana Act to include "a director, manager,

shareholder, board member, partner, or other person holding a

management position or ownership interest in the organization."

Id. § 2422(6-B).

Northeast Patients Group is a corporation that is wholly

owned by three Maine residents and that owns and operates three of

Maine's seven licensed dispensaries as a for-profit corporation.

- 4 - High Street Capital is a Delaware corporation that is owned

exclusively by non-Maine residents and that wants to acquire

Northeast Patients Group. If the deal between the two companies

were to proceed, as both High Street Capital and Northeast Patients

Group desire, then the resulting company would not be able to

function as a dispensary under Maine law in consequence of the

Maine Medical Marijuana Act's residency requirement, because the

"officers or directors" of that new company would not be only Maine

residents.

Northeast Patients Group and High Street Capital

("plaintiffs") filed this suit under 42 U.S.C § 1983 and 28 U.S.C.

§ 2201 against the Maine Department of Administrative and

Financial Services ("the Department") and Kirsten Figueroa, the

Commissioner of the Department, on December 17, 2020, in the

District of Maine to challenge the Maine Medical Marijuana Act's

residency requirement. The complaint alleges that the residency

requirement violates the dormant Commerce Clause by permitting

only in-staters to serve as "officers or directors" of

"dispensaries."

Figueroa and the Department answered the complaint on

January 29, 2021. Shortly thereafter, United Cannabis Patients,

a nonprofit advocacy group that represents medical marijuana

businesses owned by Maine residents, moved to intervene in the

- 5 - action as a defendant under Federal Rule of Civil Procedure

24(a)(2). The District Court granted the motion on March 23, 2021.

The parties filed a stipulated record that same month,

and the plaintiffs moved for summary judgment on that record.

Figueroa and the Department cross-moved for summary judgment on

the record on April 26, 2021. United Cannabis Patients opposed

the plaintiffs' motion that same day.

The District Court ruled on the parties' motions on

August 11, 2021. The District Court granted judgment for the

Department on the ground that the Department was immune from suit

under the Eleventh Amendment to the U.S. Constitution. Ne.

Patients Grp. v. Maine Dep't of Admin. & Fin. Servs., 554 F. Supp.

3d 177, 181-82 (D. Me. 2021). The District Court held with respect

to the plaintiffs' claims against Figueroa that Maine's residency

requirement violated the dormant Commerce Clause. On that basis,

it granted the plaintiffs' motion for a permanent injunction and

enjoined Figueroa from enforcing Maine's residency requirement.

Id. at 185. It also denied the defendants' motion for judgment on

the stipulated record on the same basis. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
45 F.4th 542, Counsel Stack Legal Research, https://law.counselstack.com/opinion/northeast-patients-group-v-united-cannabis-patients-and-caregivers-of-ca1-2022.